Antibacterial antisense

Current Opinion in Molecular Therapeutics

Volumn 7, Issue 2, 2005, Pages 109-113

  Geller, Bruce L ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Antisense antibacterials; Antisense antibiotics

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; FTSZ PROTEIN; LUCIFERASE; MESSENGER RNA; PEPTIDE NUCLEIC ACID; RIBOSOME RNA;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENETICS; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; DRUG POTENTIATION; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG TARGETING; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONITIS; REVIEW; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PERITONITIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; STAPHYLOCOCCUS AUREUS;

EID: 17144380407     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Miller PS, McParland KB, Jayaraman K, Ts'o PO: Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry (1981) 20(7):1874-1880.
2. Jayaraman K, McParland K, Miller P, Ts'o PO: Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3′ end of 16S rRNA. Proc Natl Acad Sci USA (1981) 78(3):1537-1541.
3. Tomizawa J, Itoh T: Plasmid CoIE1 incompatibility determined by interaction of RNA I with primer transcript. Proc Natl Acad Sci USA (1981) 78(10):6096-6100.
4. Stougaard P, Molin S, Nordstrom K: RNAs involved in copy-number control and incompatibility of plasmid R1. Proc Natl Acad Sci USA (1981) 78(10):6008-6012.
5. Rahman MA, Summerton J, Foster E, Cunningham K, Stirchak E, Weller D, Schaup HW: Antibacterial activity and inhibition of protein synthesis in Escherichia coli by antisense DNA analogs. Antisense Res Dev (1991) 1(4):319-327.
6. Gasparro FP, Edelson RL, O'Malley ME, Ugent SJ, Wong HH: Photoactivatable antisense DNA: Suppression of ampicillin resistance in normally resistant Escherichia coli. Antisense Res Dev (1991) 1(2):117-140.
7. Good L, Nielsen PE: Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat Biotechnol (1998) 16(4):355-358.
8. Good L, Nielsen PE: Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci USA (1998) 95(5):2073-2076.
9. Huycke MM, Sahm DF, Gilmore MS: Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg Infect Dis (1998) 4(2):239-249.
10. World Health Organization Report on Infectious Diseases 2000. World Health Organization (2000). http://www.who.int/infectious-disease-report/2000
11. Chambers HF: The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 7 2):178-182.
12. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 348(14):1342-1347.
13. Good L, Sandberg R, Larsson O, Nielsen PE, Wahlestedt C: Antisense PNA effects in Escherichia coli are limited by the outer membrane LPS layer. Microbiology (2000) 146(10):2665-2670.
14. Geller BL, Deere JD, Stein DA, Kroeker AD, Moulton HM, Iversen PL: Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers. Antimicrob Agents Chemother (2003) 47(10):3233-3239.
15. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE: Bacterial antisense effects of peptide-PNA conjugates. Nat Biotechnol (2001) 19(4):360-364.
16. Deere J, Iversen P, Geller BL: Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli. Antimicrob Agents Chemother (2004) 49(1):249-255.
17. Summerton J: Morpholino antisense oligomers: The case for an RNAase H-independent structural type. Biochim Biophys Acta (1999) 1489(1):141-158.
18. Kozak M: Initiation of translation in prokaryotes and eukaryotes. Gene (1999) 234(2):187-208.
19. Dryselius R, Aswasti SK, Rajarao GK, Nielsen PE, Good L: The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. Oligonucleotides (2003) 13(6):427-433.
20. Harth G, Zamecnik PC, Tang J-Y, Tabatadze D, Horwitz MA: Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the Poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc Natl Acad Sci USA (2000) 97(1):418-423.
21. Harth G, Horwitz MA, Tabatadze D, Zamecnik PC: Targeting the Mycobecterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle using antisense technology. Proc Natl Acad Sci USA (2002) 99(24):15614-15619.
22. Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L: Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther (2004) 10(4):652-659.
23. Vaara M, Porro M: Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrob Agents Chemother (1996) 40 8):1801-1805.
24. Eriksson M, Nielsen PE, Good L: Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J Biol Chem (2002) 277(9):7144-7147.
25. Ravn RT, Malik L, Giwercman B, Christensen JV, Beck F, Frimodt-Moller N: Peptide nucleic acids (PNA) based drugs are efficient in vivo antibiotics against Escherichia coli and Klebsielia pneumoniae in the mouse peritonitis/sepsis model. General Meet Am Soc Microbiol (2001) 101:Abs 26.
26. Ji Y, Zhang B, Van SF, Warren P, Woodnutt G, Burnham MKR, Rosenberg M: Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 293(5538):2266-2269.
27. Ji Y, Yin D, Fox B, Holmes DJ, Payne D, Rosenberg M: Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol Lett (2004) 231(2):177-184.
28. Yin D, Fox B, Lonetto ML, Etherton MR, Payne DJ, Holmes DJ, Rosenberg M, Ji Y: Identification of antimicrobial targets using a comprehensive genomic approach. Pharmacogenomics (2004) 5 1):101-113.
29. McKinney J, Guerrier-Takada C, Wesolowski D, Altman S: Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes. Proc Natl Acad Sci USA (2001) 98(12):6605-6610.
30. Tan X-X, Rose K, Margolin W, Chen Y: DNA enzyme generated by a novel single-stranded DNA expression vector inhibits expression of the essential bacterial cell division gene ftsZ. Biochemistry (2004) 43(4):1111-1117.